ZRG Global Life Sciences Hiring Index Second Quarter Hiring Activity at Unsurpassed Levels

ROCHELLE PARK, NJ, August 25, 2016 — ZRG Partners has announced the findings for the second quarter Global Life Sciences Hiring Index. 2016 has shown an increase in hiring demand consistently, posting 50% higher than the same period last year.

Medical Device continued to show historically high index numbers, as did BioPharma. Outsourcing / Services decreased for the second quarter in a row, however still posted higher than Q2 2015. Q2 2016 marks the first quarter that ZRG has collected data from the South America region.

ZRG European President and Global Practice Head of Life Sciences, Adam El Din commented, “The financing of startup med techs remains tough, as the number of potential acquirers has shrunk with industry consolidation. Investors still don’t see clear paths to exit. But that may be improving as the IPO market loosens.”

David Fortier, Managing Director – Global Life Sciences added, “These results are an encouraging sign for the industry. As the economy continues to strengthen slowly in the U.S., workers may be more willing to change employers and the growing inability or unwillingness of many companies to develop internal talent results in greater external hiring activity.”

About ZRG Partners

ZRG Partners, LLC is a global authority on talent management in the Life Sciences, Pharmaceutical and Medical Device markets. ZRG provides its clients with specialized global market expertise in executive recruitment, consulting and advisory work with a focus on data and analytics to drive great business decisions.

The Global Life Sciences Hiring Index analysis utilizes a proprietary algorithm that looks at hiring within selected benchmark companies in three distinct segments. The companies in the index generate over $630 billion in revenues and employ over 1.5 million people globally. ZRG Partners conducts extensive direct market research in developing the data that drives the Index.

Contact Us:
Adam El Din
European President and Global Practice Head of Life Sciences

Share This Article